Scinai Immunotherapeutics Quote - SCNI

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.5887

Bid

3.46

Ask

4.20

Volume

1,487

3.50 Day's Range 3.61

0.00 52 Week Range 0.00

Market Cap

3.005M

Previous Close

3.52

Open

3.50

Last Trade

3.47

Last Trade Time

Financial Volume

US$ 5,277

VWAP

3.5486

Average Volume (3m)

Shares Outstanding

837,310

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

Net Profit

-6.5M

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic ... BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Coml Physical, Biologcl Resh

Website

www.biondvax.com

Headquarters

Jerusalem, Jerusalem, Isr

Founded

2012

Scinai Immunotherapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SCNI. The last closing price for Scinai Immunotherapeutics was US$3.52. Over the last year, Scinai Immunotherapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Scinai Immunotherapeutics currently has 837,310 shares outstanding. The market capitalization of Scinai Immunotherapeutics is US$2.95 million.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences PR Newswire JERUSALEM, Jan. 6, 2025 JERUSALEM, Jan. 6, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd...

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc. PR Newswire JERUSALEM, Dec. 16, 2024 JERUSALEM, Dec. 16, 2024 /PRNewswire/ -- Scinai...

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board PR...

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board PR Newswire JERUSALEM, Nov. 27, 2024...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million PR Newswire JERUSALEM, Nov. 22...

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024 PR Newswire JERUSALEM, Oct. 31, 2024 JERUSALEM, Oct. 31, 2024 /PRNewswire/...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

SCNI - Frequently Asked Questions (FAQ)

What is the current Scinai Immunotherapeutics share price?

The current share price of Scinai Immunotherapeutics is US$ 3.5887

How many Scinai Immunotherapeutics shares are in issue?

Scinai Immunotherapeutics has 837,310 shares in issue

What is the market cap of Scinai Immunotherapeutics?

The market capitalisation of Scinai Immunotherapeutics is USD 2.95M

What is the 1 year trading range for Scinai Immunotherapeutics share price?

Scinai Immunotherapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the reporting currency for Scinai Immunotherapeutics?

Scinai Immunotherapeutics reports financial results in USD

What is the latest annual turnover for Scinai Immunotherapeutics?

The latest annual turnover of Scinai Immunotherapeutics is USD 9k

What is the latest annual profit for Scinai Immunotherapeutics?

The latest annual profit of Scinai Immunotherapeutics is USD -6.5M

What is the registered address of Scinai Immunotherapeutics?

The registered address for Scinai Immunotherapeutics is JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, JERUSALEM, 7403618

What is the Scinai Immunotherapeutics website address?

The website address for Scinai Immunotherapeutics is www.biondvax.com

Which industry sector does Scinai Immunotherapeutics operate in?

Scinai Immunotherapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.8M